IDSA EDUCATION AND RESEARCH FOUNDATION
IDSA EDUCATION AND RESEARCH FOUNDATION
IDSA EDUCATION AND RESEARCH FOUNDATION
Programs
Microbial Pathogenesis in Alzheimer's Disease Program
THE MICROBIAL PATHOGENESIS IN ALZHEIMER'S DISEASE PROGRAM (ALZ/ID) WAS LAUNCHED TO SUPPORT INNOVATIVERESEARCH THAT MAY LINK INFECTIOUS DISEASES AND ALZHEIMER'S DISEASE. THIS RESEARCH INCLUDES BASIC,CLINICAL AND/OR NON-TRADITIONAL RESEARCH APPROACHES ACROSS A WIDE RANGE OF DISCIPLINES INCLUDING NEUROLOGY, MICROBIOLOGY, PATHOLOGY, VIROLOGY, AND BACTERIOLOGY. IN 2022, IDSA FOUNDATION RECEIVED GRANTS TOTALING $3.3 MILLION TO FUND RESEARCH AWARDS FOR THIS PROGRAM. IN 2023, AWARDS OF APPROXIMATELY $2.5 MILLION WERE GRANTED TO RESEARCHERS, IN ADDITION TO OTHER INCURRED EXPENSES RELATED TO THE PROGRAM. DUE TO THE REQUIREMENTS OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (GAAP), THE TIMING OF THE REVENUE AND EXPENSE RECOGNITION CREATED A LARGE SURPLUS IN 2022 AND A LARGE DEFICIT IN 2023. IN 2023, THE PROGRAM LAUNCHED THE FIRST MICROBIAL PATHOGENESIS IN ALZHEIMER'S DISEASE SYMPOSIUM, PROVIDED ONGOING ASSISTANCE AND MONITORING FOR EXISTING GRANTEES. NO ADDITIONAL GRANTS WERE ISSUED IN 2024, ALTHOUGH ADDITIONAL FUNDS ARE AVAILABLE FOR GRANTS IN 2025.GeographiesNot indicatedDatesJan 1, 2024 – Dec 31, 2024Source990No causes providedNo populations provided–$97.7KG.E.R.M. Program
G.E.R.M.GERM - THE GERM PROGRAM WAS DEVELOPED TO PROVIDE MEDICAL STUDENTS WITH MENTORED CLINICAL LEARNINGAND/OR RESEARCH EXPERIENCE IN INFECTIOUS DISEASES-RELATED TOPICS, INCLUDING HIV. IN 2024, 75 PEOPLE APPLIED TO THE GERM PROGRAM AND 40 $4,000 GRANTS WERE AWARDED TOTALING $160,000. THE GOAL OF THE G.E.R.M. PROGRAM IS TO INCREASE INTEREST AMONG UNDERGRADUATE MEDICAL STUDENTS, PARTICULARLY AMONG POPULATIONS UNDERREPRESENTED IN MEDICINE, IN PURSUING ID FELLOWSHIP POST-GRADUATE TRAINING OR A CAREER IN HIV MEDICINE BY PROVIDING MENTOR-BASED RESEARCH OR CLINICAL TRAINING; IMPROVING ANALYTIC, RESEARCH AND CLINICAL SKILLS OF MEDICAL STUDENTS; INCREASING THE NUMBER AND DIVERSITY OF THE ID/HIV RESEARCH AND CLINICAL WORKFORCE. ELIGIBLE APPLICANTS INCLUDED FIRST-, SECOND-, AND THIRD YEAR MEDICAL STUDENTS AND THOSE IN COMBINED DEGREE PROGRAMS (MD/MPH, MD/PHD) FROM ACCREDITED ALLOPATHIC OR OSTEOPATHIC MEDICAL SCHOOLS IN THE U.S. APPLICATIONS WERE REVIEWED AND SCORED BY AN EXPERT PANEL OF INFECTIOUS DISEASE SPECIALISTS.GeographiesNot indicatedDatesJan 1, 2024 – Dec 31, 2024Source990No causes providedNo populations provided–$215.7KHIV Clinical Fellowship Program
HIV CLINICAL FELLOWSHIP PROGRAMHIV CLINICAL FELLOWSHIP PROGRAM - THE GOAL OF THE HIV CLINICAL FELLOWSHIP PROGRAM IS TO PROVIDE NON-ID TRAINED PHYSICIANS WITH THE MOST UPDATED BEST PRACTICES FOR TREATING PATIENTS LIVING WITH HIV. CLINICAL TRAINING INCLUDES MANAGEMENT OF ANTIRETROVIRAL THERAPY, TREATING COMMON CO-INFECTIOUS AND COMORBIDITIES AND MULTIDISCIPLINARY TEAM-BASED CARE. FELLOWS ARE SUPPORTED FOR UP TO TWO YEARS DURING WHICH TIME THEY MANAGE THE CARE OF A MINIMUM OF 30 PATIENTS, UNDER THE SUPERVISION OF AN HIV MEDICAL ASSOCIATION MENTOR. IN 2024, ONE FELLOW WAS FUNDED WITH A $120,436 AWARD.GeographiesNot indicatedDatesJan 1, 2024 – Dec 31, 2024Source990No causes providedNo populations provided–$126K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)